As depicted in Figure 7, the results of our study demonstrate that the HH-GLI signal inhibitor GANT61 has an antitumor effect on the malignant character of undifferentiated HCC cells with the mesenchymal phenotype. The gene discussed is GLI1; the disease is hepatocellular carcinoma.